BusinessDiagnosticsMedical InnovationsTechnology

Use of Light Technology Avoids Blood Clotting

1 Mins read

ThromboVision is a medical devices company that has developed a technological platform to determine an individual’s susceptibility to thrombosis, an adverse blood clot formation that can cause blockage of blood vessels leading to heart attack or stroke. The company uses a proprietary light scattering technology to measure an individual’s platelet levels, the cells in the body that lead to the formation of blood clots, thereby determining the patient’s risk factor for thrombosis. The company’s apparatus is simple and inexpensive to use, making it beneficial in both doctor’s office and hospital settings. Adverse blood clots in the systemic circulation can cause blood vessel blockage leading to a heart attack or stroke, yet diagnostics that can determine a patient’s susceptibility to blood clotting is lacking.

Related posts
BusinessHospital Administration

4 Ways to Enhance Clinical Documentation to Resolve Headaches as a Provider

2 Mins read
In the healthcare sector, information is vital to improving clinical outcomes and saving lives. This is the reason why institutions are always…

New Medical Laboratories Are the Key to Diagnostics Research

3 Mins read
The development of the COVID-19 vaccine was a miracle in medical research. It shows the incredible importance of medical innovation in the…

How Rapid Blood Testing Solves Blood Lab Wait Time Issues

3 Mins read
In early November 2020, Steven Hill* experienced a concerning and prolonged bout of nausea, weakness, and a host of other symptoms that…